Title

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

Date of this Version

10-9-2015

Document Type

Journal Article

Publication Details

Citation only

Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., Cooper, M., Glasziou, P., Grobbee, D., Hamet, P., Harrap, S., Heller, S., Lisheng, L., Mancia, G., Marre, M., Matthews, D., Mogensen, C., Perkovic, V., Poulter, N., Rodgers, A., Williams, B., MacMahon, S., Patel, A., & Woodward, M. (2014). Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New England Journal of Medicine, 371(15), 1392-1406.

Access the journal

© Copyright, Massachusetts Medical Society, 2014

2014 HERDC Submission

NHMRC Project Grant

ISSN

0028-4793

Abstract

The benefits with respect to mortality that had been observed among patients originally assigned to blood-pressure–lowering therapy were attenuated but still evident at the end of follow-up. There was no evidence that intensive glucose control during the trial led to long-term benefits with respect to mortality or macrovascular events.

This document is currently not available here.

Share

COinS
 

This document has been peer reviewed.